Form 4: Ashland Executive Granted Equity Awards
Insider Transaction Disclosure
Ashland Inc. Senior Vice President Robin E. Lampkin received grants of Restricted Stock Units and Stock Appreciation Rights as part of the company's incentive plan.
Summary
- Robin E. Lampkin, SVP, General Counsel and Secretary of Ashland Inc. (ASH), was granted equity awards.
- The awards include 3,965 Restricted Stock Units (RSUs) on November 19, 2025.
- Each RSU represents a right to receive one share of ASH Common Stock.
- The RSUs will vest in three equal installments, beginning one year from the grant date, contingent on continuous employment.
- Additionally, 8,922 Stock Appreciation Rights (SARs) were granted on November 19, 2025, with an exercise price of $50.58.
- The SARs become exercisable ratably over three years, starting on the first anniversary of the grant date, and expire on November 19, 2035.
- These grants were made pursuant to Ashland's incentive plan, which was approved by shareholders, and are exempt under Rule 16b-3.
Sentiment
Score: 6
Explanation: The filing is a routine disclosure of executive compensation, which is generally a neutral to slightly positive event as it aligns management incentives with shareholder interests. It does not contain information that would significantly alter the company's financial outlook or operational performance.
Positives
- The grant of Restricted Stock Units and Stock Appreciation Rights aligns the executive's interests with those of shareholders.
- Equity awards serve as an incentive for the executive's continued employment and performance.
Future Outlook
The vesting schedules for both the Restricted Stock Units and Stock Appreciation Rights are contingent on the reporting person's continuous employment with Ashland Inc., indicating an expectation of continued service.
Industry Context
The granting of equity awards such as Restricted Stock Units and Stock Appreciation Rights is a common practice in executive compensation across various industries, designed to attract, retain, and motivate key personnel by aligning their financial interests with the long-term performance of the company.
Comparison to Industry Standards
- The structure of these equity grants, including multi-year vesting schedules, is consistent with standard executive compensation practices observed in publicly traded companies, aiming to foster long-term commitment and performance.
- The use of both RSUs (full value equity) and SARs (leveraged equity appreciation) is a common approach to balance retention and performance incentives, similar to compensation packages at peer companies in the specialty chemicals sector.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation Plan | The equity grants were made pursuant to Ashland's incentive plan, which was approved by the shareholders. | 11/19/2025 | Reinforces shareholder oversight and approval of executive compensation structures, aligning with good corporate governance practices. |
Stakeholder Impact
- Shareholders: The grants align the interests of a key executive with shareholders, potentially leading to better long-term performance.
- Employees: The incentive plan may serve as a model for broader employee incentive programs, fostering a performance-driven culture.
Next Steps
- The Restricted Stock Units will vest in three equal installments, beginning one year from the grant date of November 19, 2025.
- The Stock Appreciation Rights will become exercisable ratably over three years, starting on the first anniversary of the grant date of November 19, 2025.
Key Dates
| Date | Description |
|---|---|
| 11/19/2025 | Date of grant for Restricted Stock Units (RSUs) and Stock Appreciation Rights (SARs). |
| 11/19/2026 | First vesting date for RSUs and first exercisability date for SARs (one year from grant date). |
| 11/19/2035 | Expiration date for Stock Appreciation Rights (SARs). |
| 11/21/2025 | Date the Form 4 was signed and filed. |
Keywords
Ashland Inc., ASH, Form 4, Restricted Stock Units, RSU, Stock Appreciation Rights, SAR, Executive Compensation, Equity Grant, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.